Login:
Share:
Email Facebook Twitter

HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS Services
Share ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers

Round table discussion - PRECIOUS METALS


Latest Share Chat

SEPU. Sepura hits t-
e high ground with ..

0O1W. Hi, Hope y-
u and your family a..

STOB. Another case
f stick to what yo..

NTOG. It contained
few variables and ..

FRR. Hard to believ-
e the report is abo..

NTOG. I don't know-
if Billy is around,..

PGR. "Cholokka-
indy bears the hall..

MOGP. thanks for th
post this is simil..

VAL. Paisly I think
the crying baby wu..

IMM. And yes, I do
know what you mean...



Home
::
Share Prices
::
Ark Therapeutics Share Price
::
Ark Therapeutics Regulatory News
::
Bookmark this page

Ark Therapeutics Regulatory News (AKT)


AKT Share Price
AKT Share Price
AKT News
AKT Share News
AKT Share Charts
AKT Share Charts
AKT Forum
AKT Share Chat
AKT Share Trades
AKT Share Trades
AKT RNS
AKT RNS
AKT Directors Deals
AKT Directors Deals
AKT Live Share Price
AKT Live Share Price
AKT Broker Tips / Recommendations
AKT Broker Ratings
Get AKT SMS Alerts
Get AKT
SMS Updates
AKT Financial Diary
AKT Financial Diary
AKT Fundamental Data
AKT Fundamentals
AKT Level 2 Console
AKT Level 2 Console
AKT Media
AKT Media

Regulatory News for Ark Therapeutics (AKT)


Share Price: 0.41Bid: 0.37Ask: 0.45Change: -0.03 (-6.82%)Faller - Ark Ther Grp
Spread: 0.08Spread as %: 21.62%Open: 0.41High: 0.44Low: 0.44Yesterday’s Close: 0.44

AKT Share News
AKT ShareCast
AKT Regulatory

Categories:   Date:


Holding(s) in Company

Fri, 18th May 2012 12:02

RNS Number : 6665D
Ark Therapeutics Group PLC
18 May 2012
 

?

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

  ARK THERAPEUTICS GROUP PLC

2 Reason for the notification (please tick the appropriate box or boxes):

 

An acquisition or disposal of voting rights

 v

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


 

An event changing the breakdown of voting rights


 

Other (please specify):

 


3. Full name of person(s) subject to the notification obligation:

 

1Lansdowne Partners Limited being the General Partner of Lansdowne Partners Limited Partnership

 

2Lansdowne Partners International Limited

4. Full name of shareholder(s) (if different from 3.):

 

 HSBC Client Holdings UK Ltd

 

(Registered Shareholder)

5. Date of the transaction and date on which the threshold is crossed or reached:

 

 

15/5/12

6. Date on which issuer notified:

 

 

17/5/12

7. Threshold(s) that is/are crossed or reached:

 

 

5%

8. Notified details:

A: Voting rights attached to shares

 

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights

Direct

Direct

Indirect

Direct

Indirect

 Ordinary Shares

11,748,373

11,748,373



Below 5%


Below 5%

 GB0034251727

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial
instrument

Expiration
date

Exercise/
Conversion
Period

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

 

% of voting
rights






C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

 

Type of financial
instrument

Exercise
price

Expiration
date

Exercise/
Conversion
period

Number of voting
rights instrument
refers to

% of voting rights

 






Nominal

Delta

 



Total (A+B+C)

 

Number of voting rights

Percentage of voting rights

 Below 5%

 Below 5%

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

Lansdowne Partners International Limited is the parent undertaking of Lansdowne Partners Limited

Proxy Voting:

 

10. Name of the proxy holder:

 

 Lansdowne Partners Limited

11. Number of voting rights proxy holder will cease to hold:

 


12. Date on which proxy holder will cease to hold voting rights:

 


 

13. Additional information:

 


14. Contact name:

 

 Kamran Salahuddin

15. Contact telephone number:

 

 +44 20 7290 5500

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUWRARUAAVAAR


Related Shares: Ark Therapeutics Group (AKT).




DateSourceHeadlineCategory
17-May-13 07:00RNSInterim Management StatementResults and Trading Reports
16-May-13 13:20RNSHolding(s) in CompanyHolding(s) in Company
08-May-13 18:09RNSHolding(s) in CompanyHolding(s) in Company
08-May-13 17:47RNSHolding(s) in CompanyHolding(s) in Company
02-May-13 13:45RNSHolding(s) in CompanyHolding(s) in Company
01-May-13 16:35RNSPrice Monitoring ExtensionCompany Announcement - General
30-Apr-13 07:00RNSFinal ResultsResults and Trading Reports
26-Apr-13 16:50RNSHolding(s) in CompanyHolding(s) in Company
24-Apr-13 15:47RNSHolding(s) in CompanyHolding(s) in Company
26-Mar-13 16:40RNSSecond Price Monitoring ExtnCompany Announcement - General
26-Mar-13 16:35RNSPrice Monitoring ExtensionCompany Announcement - General
22-Mar-13 11:50RNSHolding(s) in CompanyHolding(s) in Company
20-Mar-13 13:15RNSHolding(s) in CompanyHolding(s) in Company
19-Mar-13 09:47RNSHolding(s) in CompanyHolding(s) in Company
15-Mar-13 12:01RNSTermination of Offer Period and Rule 10.8 WaiverCompany Announcement - General
26-Feb-13 17:35RNSHolding(s) in CompanyHolding(s) in Company
25-Feb-13 11:27RNSHolding(s) in CompanyHolding(s) in Company
22-Feb-13 14:41RNSHolding(s) in CompanyHolding(s) in Company
21-Feb-13 13:24PRNABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics plcMergers, Acquisitions and Disposals
21-Feb-13 10:56RNSHolding(s) in CompanyHolding(s) in Company
20-Feb-13 12:54PRNABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics plcMergers, Acquisitions and Disposals
19-Feb-13 16:40RNSSecond Price Monitoring ExtnCompany Announcement - General
19-Feb-13 16:35RNSPrice Monitoring ExtensionCompany Announcement - General
15-Feb-13 10:39PRNABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics Group plcMergers, Acquisitions and Disposals
12-Feb-13 12:25RNSHolding(s) in CompanyHolding(s) in Company
07-Feb-13 15:05RNSHolding(s) in CompanyHolding(s) in Company
07-Feb-13 13:41PRNABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics GroupMergers, Acquisitions and Disposals
06-Feb-13 11:18PRNABERFORTH PARTNERS LLP - Form 8.3 - Ark Therapeutics GroupMergers, Acquisitions and Disposals
06-Feb-13 11:02RNSForm 8 (OPD)Mergers, Acquisitions and Disposals
05-Feb-13 16:35RNSPrice Monitoring ExtensionCompany Announcement - General



Regulatory news is displayed end of day, each day at 19:00.
Sign up for Live Prices



Home  |  Share Prices  |  Share Chat  |  Finance News  |  Blogs  |  Live Prices  |  Contact  |  About Us  |  Sitemap  |  Web Design by Revive DM  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NETbuilder and Interactive Data. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk!
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.